Lifecore Biomedical, Inc. \De\ (LFCR) Receivables - Net (2016 - 2025)
Lifecore Biomedical, Inc. \De\ has reported Receivables - Net over the past 15 years, most recently at $13.5 million for Q2 2025.
- For Q2 2025, Receivables - Net fell 16.82% year-over-year to $13.5 million; the TTM value through May 2025 reached $13.5 million, down 16.82%, while the annual FY2025 figure was $13.5 million, 57.52% down from the prior year.
- Receivables - Net for Q2 2025 was $13.5 million at Lifecore Biomedical, Inc. \De\, down from $16.1 million in the prior quarter.
- Over five years, Receivables - Net peaked at $39.7 million in Q1 2022 and troughed at $10.8 million in Q3 2023.
- A 5-year average of $24.8 million and a median of $27.5 million in 2021 define the central range for Receivables - Net.
- Biggest five-year swings in Receivables - Net: plummeted 66.28% in 2023 and later skyrocketed 181.34% in 2024.
- Year by year, Receivables - Net stood at $27.5 million in 2021, then dropped by 0.13% to $27.5 million in 2022, then plummeted by 60.77% to $10.8 million in 2023, then skyrocketed by 181.34% to $30.3 million in 2024, then crashed by 55.33% to $13.5 million in 2025.
- Business Quant data shows Receivables - Net for LFCR at $13.5 million in Q2 2025, $16.1 million in Q1 2025, and $30.3 million in Q4 2024.